Trupanion, Inc. (NASDAQ:TRUP) Shares Sold by Corton Capital Inc.

Corton Capital Inc. reduced its position in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 54.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,983 shares of the financial services provider's stock after selling 5,953 shares during the period. Corton Capital Inc.'s holdings in Trupanion were worth $240,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the company. Balyasny Asset Management L.P. raised its stake in shares of Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock worth $40,548,000 after buying an additional 661,559 shares during the period. BNP Paribas Financial Markets raised its position in Trupanion by 170.7% during the fourth quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock worth $16,248,000 after acquiring an additional 212,545 shares during the period. Freestone Grove Partners LP acquired a new position in Trupanion during the fourth quarter worth $7,776,000. Baillie Gifford & Co. lifted its holdings in Trupanion by 26.6% during the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock valued at $33,806,000 after purchasing an additional 147,341 shares in the last quarter. Finally, First Trust Advisors LP acquired a new stake in shares of Trupanion in the fourth quarter valued at about $7,083,000.

Trupanion Price Performance

Shares of NASDAQ:TRUP traded up $0.25 during midday trading on Friday, hitting $44.31. The company had a trading volume of 360,833 shares, compared to its average volume of 645,668. Trupanion, Inc. has a twelve month low of $25.90 and a twelve month high of $57.90. The stock has a market cap of $1.90 billion, a price-to-earnings ratio of -192.65, a price-to-earnings-growth ratio of 6.02 and a beta of 1.72. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The business's 50-day simple moving average is $36.70 and its 200-day simple moving average is $44.61.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.05) by $0.02. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The business had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. During the same quarter in the previous year, the firm earned ($0.16) EPS. The company's quarterly revenue was up 11.7% compared to the same quarter last year. On average, research analysts predict that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on TRUP. Stifel Nicolaus decreased their price target on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research note on Thursday, February 20th. Lake Street Capital lowered their price target on Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Finally, Piper Sandler dropped their price target on Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $51.80.

Insider Activity

In other news, CFO Fawwad Qureshi sold 1,373 shares of the company's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total value of $46,984.06. Following the transaction, the chief financial officer now owns 2,416 shares of the company's stock, valued at $82,675.52. This represents a 36.24 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Margaret Tooth sold 2,294 shares of the stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total value of $72,008.66. Following the transaction, the chief executive officer now owns 118,784 shares of the company's stock, valued at approximately $3,728,629.76. This represents a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,792 shares of company stock valued at $1,122,802 in the last 90 days. Company insiders own 5.50% of the company's stock.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.